XML 127 R7.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements Of Changes In Stockholders' Equity - USD ($)
$ in Millions
Total
Common Stock
Common Stock, Held In Treasury [Member]
Additional Paid-In Capital [Member]
Retained Earnings [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Noncontrolling Interests [Member]
Beginning balances at Dec. 31, 2016 $ 3,892 $ 1 $ (319) $ 551 $ 3,412 $ (121) $ 368
Beginning balance, shares issued at Dec. 31, 2016   134,651,380          
Beginning balance, Treasury Stock, Shares at Dec. 31, 2016     5,726,377        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income attributable to Westlake Chemical Corporation 1,304       1,304    
Net income attributable to noncontrolling interests 35           35
Net income 1,339            
Other comprehensive income 133         128 5
Common stock repurchased, shares     0        
Shares issued—stock- based compensation, shares   0 (493,502)        
Shares issued—stock-based compensation 11 $ 0 $ 17 (6)      
Stock-based compensation (in shares)     0        
Stock-based compensation 14   $ 0 14      
Dividends declared (103)       (103)    
Distributions to noncontrolling interests (28)           (28)
Issuance of Westlake Chemical Partners LP common units 111     (4)     115
Ending balances at Dec. 31, 2017 5,369 $ 1 $ (302) 555 4,613 7 495
Ending balance, shares issued at Dec. 31, 2017   134,651,380          
Ending balance, Treasury Stock, Shares at Dec. 31, 2017     5,232,875        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Reclassification of certain tax effects to retained earnings 0       (13) 13  
Net income attributable to Westlake Chemical Corporation 996       996    
Net income attributable to noncontrolling interests 38           38
Net income 1,034            
Other comprehensive income (84)         (82) (2)
Common stock repurchased, shares     1,368,881        
Common stock repurchased (106)   $ (106)       0
Shares issued—stock- based compensation, shares   0 (418,631)        
Shares issued—stock-based compensation 9 $ 0 $ 26 (17)      
Stock-based compensation (in shares)     0        
Stock-based compensation 18   $ 0 18      
Dividends declared (120)       (120)    
Distributions to noncontrolling interests (45)           (45)
Ending balances at Dec. 31, 2018 $ 6,076 $ 1 $ (382) 556 5,477 (62) 486
Ending balance, shares issued at Dec. 31, 2018 134,651,380 134,651,380          
Ending balance, Treasury Stock, Shares at Dec. 31, 2018 6,183,125   6,183,125        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Cumulative effect of accounting change $ 1       1    
Net income attributable to Westlake Chemical Corporation 421       421    
Net income attributable to noncontrolling interests 41           41
Net income 462            
Other comprehensive income (11)         (12) 1
Common stock repurchased, shares     517,712        
Common stock repurchased (30)   $ (30)       0
Shares issued—stock- based compensation, shares   0 (434,228)        
Shares issued—stock-based compensation $ 1 $ 0 $ 35 (25) (9)    
Stock-based compensation (in shares) (18,635)   0        
Stock-based compensation $ 24   $ 0 24      
Dividends declared (132)       (132)    
Distributions to noncontrolling interests (50)           (50)
Issuance of Westlake Chemical Partners LP common units 63     (2)     65
Ending balances at Dec. 31, 2019 $ 6,403 $ 1 $ (377) $ 553 $ 5,757 $ (74) $ 543
Ending balance, shares issued at Dec. 31, 2019 134,651,380 134,651,380          
Ending balance, Treasury Stock, Shares at Dec. 31, 2019 6,266,609   6,266,609